display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/adv melanoma (mML)
mML - L2 - all population
ipilimumab alone MDX010 Ipi vs gp100
Ipilimumab (10 mg/kg) CA184-004 Ascierto ...

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons